CIBMTR Reporting Implementation Guide
0.1.4 - Trial Use 1

This page is part of the CIMBTRReporting (v0.1.4: Trial Use 1) based on FHIR R4. This is the current published version. For a full list of available versions, see the Directory of published versions

Table of Contents

..0 Table of Contents
...1 Home
...2 Direct FHIR STU 3
...3 Artifacts Summary
....3.1 CIBMTR Observation Laboratory Results: Priority Variables
....3.2 CIBMTR Observation Laboratory Results Profile (us-core)
....3.3 CIBMTR Patient Profile (us-core)
....3.4 Auto Differential panel - Blood (57023-4)
....3.5 CBC panel - Blood by Automated count (58410-2)
....3.6 CBC W Auto Differential panel - Blood (57021-8)
....3.7 CBC W Differential panel, method unspecified - Blood (69742-5)
....3.8 CBC W Ordered Manual Differential panel - Blood (57782-5)
....3.9 Differential panel, method unspecified - Blood (69738-3)
....3.10 Erythrocyte morphology panel - Blood (58408-6)
....3.11 GVHD Type Value Set
....3.12 Leukocyte morphology panel - Blood (58407-8)
....3.13 Manual Differential panel - Blood (24318-8)
....3.14 Platelet morphology panel - Blood (58406-0)
....3.15 Presence Answer List
....3.16 CIBMTR Priority Variables Value Set (FY21)
....3.17 CIBMTR Priority Variables Value Set for Epic App (FY21)
....3.18 Smear morphology panel - Blood (34994-4)
....3.19 NIH Common Data Elements for CIBMTR
....3.20 NIH Common Data Element Value Meanings for CIBMTR
....3.21 AlbuminObservation
....3.22 BasophilsObservation
....3.23 EosinophilsObservation
....3.24 HemoglobinObservation
....3.25 LeukocytesObservation
....3.26 MetamyelocytesObservation
....3.27 NeutrophilsObservation
....3.28 PatientExample1
....3.29 PatientExample2
....3.30 PatientExample3
....3.31 PatientExample4
....3.32 PatientExample5